Robert Daniels

Venture Partner

2021 - Current

Joined the Brandon team to get back involved with some exciting early stage biotech opportunities.

Head Elastagen

2020 - 2021

Worked with incoming Abbvie staff following the acquisition of Allergan to ensure the Elastagen business, as part of Allergan Aesthetics, was successfully integrated into Abbvie's Asset Strategy, operations and manufacturing teams.

Head Elastagen

2018 - 2020

Led the integration of Elastagen's business and pipeline products into Allergan, interacting cross-functionally with regs, clinical, biologics and device groups in US and Europe.

Chief Executive

2008 - 2018

Director and CEO, led the business from lab bench start up in 2008 to a global operation with a late stage clinical pipeline. Led the sale & integration of the business into Allergan following Elastagen's acquisition for ~A$350M, and again into Abbvie following its acquisition of Allergan.

Associate

2008 - 2010

VP Asia Pacific

2007 - 2008

Chief Commercial Officer

2004 - 2007

COO

2001 - 2003